---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-115043"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2026-10-09T20:10:18+00:00"
generated_at: "2026-10-12T15:10:46.972731+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Accendra Health receives NYSE notice over sub-$1 average share price, plans to cure

## Summary
- NYSE notified Accendra on Oct. 6, 2026 that ACH's average closing price was below $1.00 over 30 consecutive trading days.
- Accendra has six months from the notice to regain compliance; closing price and 30-day average must be at least $1.00.
- Accendra intends to notify NYSE within 10 business days of its plan to cure, including a possible reverse stock split subject to stockholder approval.
- A reverse split, if necessary, would be subject to approval no later than the annual meeting anticipated in May 2027.
- Accendra says the notice has no immediate delisting impact and does not affect business, operations or SEC reporting obligations.

## SEC filing metadata
- accession: 0001104659-26-115043
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2026-10-09T20:10:18+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000110465926115043/0001104659-26-115043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000110465926115043/ach-20261006x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-115043
- JSON: https://secwatch.observer/filing/0001104659-26-115043.json
- Plain text: https://secwatch.observer/filing/0001104659-26-115043.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.